The effects of high-dose intravenous immunoglobulin on plasma protein and lipid levels in the patients with Kawasaki disease
![]() |
Lee, Keun Young
(Department of Pediatrics, College of Medicine, The Catholic University of Korea)
Kim, Dong-Un (Department of Pediatrics, College of Medicine, The Catholic University of Korea) Lee, Hyun Seung (Department of Pediatrics, College of Medicine, The Catholic University of Korea) Jang, Pil Sang (Department of Pediatrics, College of Medicine, The Catholic University of Korea) Kim, Young-Hoon (Department of Pediatrics, College of Medicine, The Catholic University of Korea) Kim, Jin Tack (Department of Pediatrics, College of Medicine, The Catholic University of Korea) Kim, Hyun Hee (Department of Pediatrics, College of Medicine, The Catholic University of Korea) Lee, Kyung-Yil (Department of Pediatrics, College of Medicine, The Catholic University of Korea) Lee, Joon-Sung (Department of Pediatrics, College of Medicine, The Catholic University of Korea) |
1 | Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association. Pediatrics 2004;114:1708-33. DOI ScienceOn |
2 | Koffman BM, Dalakas MC. Effect of high-dose intravenous immunoglobulin on serum chemistry, hematology, and lymphocyte subpopulations; Assessments based on controlled treatment trials in patients with neurological diseases. Muscle Nerve 1997;20:1102-7 DOI ScienceOn |
3 | Lobo ED, Hansen RJ, Balthasar JP. Antibody phamokinetics and pharmacodynamics. J Pharm Sci 2004;93:2645-8 DOI ScienceOn |
4 | Clarlton B, Schindhelm K, Smeby LC, Farrell PC. Analysis of immunoglobulin G kinetics in the non-steady state. J Lab Clin Med 1985;105:312-20 |
5 | Galli E, Barbieri C, Cantani A, Solano A, Longhi MA, Businco L. Treatment with gammaglobulin preparation for intravenous use in children with humoral immunodeficiency: clinical and immunologic follow up. Ann Allergy 1990;64: 147-50 |
6 | Greenbaum LA. Electrolyte and acid base disorders. In : Behrman RE, Kliegman RM, Jenson HB, editors. Nelson Textbook of Pediatrics. 17th ed. Philadelphia : Saunders 2004:191-242 |
7 | Cabana VG, Gidding SS, Getz GS, Chapman J, Shulman ST. Serum amyloid A and high density lipoprotein participate in the acute phase response of Kawasaki disease. Pediatr Res 1997;42:651-5 DOI ScienceOn |
8 | Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502 |
9 | Goodsell DS, Olson AJ. Soluble proteins : Size, shape and function. Trends Biochem Sci 1993;18:65-8 DOI ScienceOn |
10 | Shulman ST. IVGG therapy in Kawasaki disease: mechanism(s) of action. Clin Immunol Immunopathol 1989;53:S141-6 DOI ScienceOn |
11 | Chiang AN, Hwang B, Shaw GC, Lee BC, Lu JH, Meng CC, Chou P. Changes in plasma levels of lipids and lipoprotein composition in patients with Kawasaki disease. Clin Chim Acta 1997;260:15-26 DOI ScienceOn |
12 | Mitra A, Singh S, Devidayal, Khullar M. Serum lipids in north indian children treated for Kawasaki Disease. Int Heart J 2005;46:811-7 DOI |
13 | Marcinkiewicz J, Szymanowska Z, Mazurrek A. Immunoregulatory mechansims of action of intravenous gammaglobulin in Kawasaki syndrome. Przegl Lek 1998;55:611-3 |
14 | Newberger JW, Takahashi M, Beiser AS, Burns JC, Chung KJ, Melish ME: A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of Kawasaki syndrome. N Engl J Med 1991;324:1633-9 DOI ScienceOn |
15 | Leung DY. Kawasaki syndrome: immunomodulatory benefit and potential toxin neutralization by intravenous globulin. Clin Exp Immunol 1996;104:49-54 |
16 | Ross MH, Romrell LJ, Kaye GI. Histology : A text and atlas. 3rd ed. Baltimore : Williams & Wilkins, 1995:310-11 |
17 | Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA 1970;76;333-7 |
18 | Toubi E, Etzioni A. Intravenous immunoglobulin in immunodeficiency states: state of the art. Clin Rev Allergy Immunol 2005;29:167-72 DOI ScienceOn |
19 | Okada T, Harada K, Okuni M. Serum HDL-cholesterol and lipoprotein fraction in Kawasaki disease(acute mucocutaneous lymph node syndrome). Jpn Circ J 1982;46:1039-44 DOI ScienceOn |
20 | Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Hayashidera T, et al. High-dose intravenous gammaglobulin for Kawasaki disease. Lancet 1984;2(8411):1055-8 |
21 | Nakano H, Ueda K, Saito A, Nojima K. Repeated quantitative angiograms in coronary arterial aneurysm in Kawasaki disease. Am J Cardiol 1985;56:846-51 DOI ScienceOn |
22 | Rader DJ, Hobbs HH. Disorders of lipoprotein metabolism. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, editors. Harrison's principles of Internal Medicine. 16th ed. McGraw-Hill Companies, Inc. 2005: 2286-98 |
23 | Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association. Circulation 2004;110:2747-71 DOI ScienceOn |
24 | Quartier P, Debre M, De Blic J, de Sauverzac R, Sayegh N, Jabado N, et al. Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patient. J Pediatr 1999;134:589-96 DOI ScienceOn |
25 | Kato H, Koike S, Yamamoto M, Ito Y, Yano E. Coronary aneurysm in infants and young children with acute febrile mucocutaneous lymph node syndrome. J Pediatr 1975;86: 892-8 DOI |
26 | Lee KY, Han JW, Lee JS, Whang KT. Alteration of biochemical profiles after high-dose intravenous immunoglobulin administration in Kawasaki disease. Acta Paediatr 2002; 91:64-7 |
![]() |